• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1 Back to Search Results
Model Number 801074
Device Problem Out-Of-Box Failure (2311)
Patient Problem No Patient Involvement (2645)
Event Date 04/07/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The voltage from the o2 sensor with 100% oxygen was 2.141 volts direct current (vdc), which was within specification.With the blender setpoint at 30%, the central control monitor (ccm) reported 29.5%, the external o2 analyzer showed the actual o2 as 26.3%.The srt installed a new o2 sensor, ran verification test and the unit operated to manufacturer specifications and was returned to clinical use.The suspect part was returned for further evaluation.During the laboratory evaluation, o2 sensor accuracy was not within specifications during initial testing after calibration.After 20 minutes of testing a second calibration was performed, o2 sensor accuracy was within specifications.The product surveillance technician (pst) installed the returned o2 sensor into a lab-use only (luo) epgs and connected the epgs to a system-1 simulator and ccm.He connected the epgs to o2 and air, and entered a perfusion screen on the ccm.After the 15 minute warm-up period, calibration of the o2 sensor was initiated and passed.The measurement of the direct current (d/c) output voltage from the o2 sensor at 5 liters per minute (l/min) and 100% o2 was 1.94 volts (v) which is within the specification of 0.55-2.758 volts.The pst tested the accuracy of o2% as shown in the table below: o2% set point = 100% ccm reading = 100% external analyzer reading = 97.8%; o2% set point = 80% ccm reading = 80.1% external analyzer reading = 72.2%; o2% set point = 60% ccm reading = 60.5% external analyzer reading = 55.4%; o2% set point = 40% ccm reading = 39.6% external analyzer reading = 36.4%; o2% set point = 30% ccm reading = 29.4% external analyzer reading = 26.5%; o2% set point = 21% ccm reading = 21.9% external analyzer reading = 20.4%.After 20 minutes of testing, a second calibration was performed and o2% accuracy was within specifications as shown in the table below: o2% set point = 100% ccm reading = 99.0% external analyzer reading = 97.1%; o2% set point = 80% ccm reading = 80.4% external analyzer reading = 79.0%; o2% set point = 60% ccm reading = 60.3% external analyzer reading = 59.3%; o2% set point = 40% ccm reading = 39.8% external analyzer reading = 39.3%; o2% set point = 30% ccm reading = 29.2% external analyzer reading = 29.4%; o2% set point = 21% ccm reading = 20.2% external analyzer reading = 20.6%.Specification for oxygen accuracy: +/- 3% of o2 set point; specification of ccm oxygen reading: +/- 7% of o2 set point.
 
Event Description
Upon receipt of the device, the service repair technician (srt) reported that the electronic patient gas system (epgs) failed the oxygen (o2) sensor reading accuracy portion of the verification test during phase 2 testing.This is considered an "out of box" falure.There was no patient involvement.
 
Manufacturer Narrative
The reported complaint was confirmed.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO ADVANCED PERFUSION SYSTEM 1
Type of Device
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORP.
6200 jackson road
ann arbor MI 48103
Manufacturer Contact
jan winder
6200 jackson road
ann arbor, MI 48103
7346634145
MDR Report Key5619460
MDR Text Key44472840
Report Number1828100-2016-00297
Device Sequence Number1
Product Code DTQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K022947
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date06/21/2016
Device Model Number801074
Device Catalogue Number801074
Device Lot Number12901-028
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/08/2016
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 04/07/2016
Initial Date FDA Received04/29/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/27/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/22/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-